DocGo Inc has a consensus price target of $9.69 based on the ratings of 36 analysis. The 3 most-recent analyst ratings were released by BTIG, Canaccord Genuity, and Needham on May 9, 2024, respectively. With an average price target of $6.33 between BTIG, Canaccord Genuity, and Needham, there's an implied 116.89% upside for DocGo Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/09/2024 | Buy Now | 139.73% | BTIG | David Larsen | $11 → $7 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | 71.23% | Canaccord Genuity | Richard Close | $9 → $5 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | 139.73% | Needham | Ryan MacDonald | $10 → $7 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | 71.23% | Cantor Fitzgerald | Sarah James | $11 → $5 | Maintains | Overweight | Get Alert |
04/30/2024 | Buy Now | 122.6% | Stifel | David Grossman | $8 → $6.5 | Maintains | Buy | Get Alert |
04/11/2024 | Buy Now | 208.22% | Canaccord Genuity | Richard Close | $10 → $9 | Maintains | Buy | Get Alert |
04/10/2024 | Buy Now | 173.97% | Stifel | David Grossman | $11 → $8 | Maintains | Buy | Get Alert |
04/10/2024 | Buy Now | 276.71% | BTIG | David Larsen | $13 → $11 | Maintains | Buy | Get Alert |
02/29/2024 | Buy Now | 276.71% | Cantor Fitzgerald | Sarah James | $13 → $11 | Maintains | Overweight | Get Alert |
02/29/2024 | Buy Now | 242.47% | Canaccord Genuity | Richard Close | $11 → $10 | Maintains | Buy | Get Alert |
02/29/2024 | Buy Now | 242.47% | Needham | Ryan MacDonald | $14 → $10 | Maintains | Buy | Get Alert |
02/23/2024 | Buy Now | 276.71% | Stifel | David Grossman | $12 → $11 | Maintains | Buy | Get Alert |
11/27/2023 | Buy Now | 310.96% | Stifel | David Grossman | → $12 | Reiterates | Buy → Buy | Get Alert |
10/02/2023 | Buy Now | 345.21% | Cantor Fitzgerald | Sarah James | → $13 | Reiterates | Overweight → Overweight | Get Alert |
09/19/2023 | Buy Now | 345.21% | BTIG | David Larsen | $15 → $13 | Maintains | Buy | Get Alert |
09/18/2023 | Buy Now | 310.96% | Stifel | David Grossman | → $12 | Reiterates | Buy → Buy | Get Alert |
09/18/2023 | Buy Now | 379.45% | Needham | Ryan MacDonald | → $14 | Reiterates | Buy → Buy | Get Alert |
09/14/2023 | Buy Now | 345.21% | Cantor Fitzgerald | Sarah James | → $13 | Reiterates | Overweight → Overweight | Get Alert |
09/07/2023 | Buy Now | 379.45% | Needham | Ryan MacDonald | → $14 | Reiterates | Buy → Buy | Get Alert |
08/23/2023 | Buy Now | 379.45% | Needham | Ryan MacDonald | → $14 | Reiterates | Buy → Buy | Get Alert |
08/22/2023 | Buy Now | 379.45% | Needham | Ryan MacDonald | → $14 | Reiterates | Buy → Buy | Get Alert |
08/18/2023 | Buy Now | 413.7% | BTIG | David Larsen | → $15 | Initiates | → Buy | Get Alert |
08/08/2023 | Buy Now | 379.45% | Needham | Ryan MacDonald | → $14 | Reiterates | Buy → Buy | Get Alert |
07/31/2023 | Buy Now | 310.96% | Stifel | David Grossman | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
06/21/2023 | Buy Now | 310.96% | Stifel | David Grossman | → $12 | Reiterates | Buy → Buy | Get Alert |
06/21/2023 | Buy Now | 345.21% | Canaccord Genuity | Richard Close | → $13 | Reiterates | Buy → Buy | Get Alert |
06/21/2023 | Buy Now | 379.45% | Needham | Ryan MacDonald | → $14 | Reiterates | Buy → Buy | Get Alert |
04/21/2023 | Buy Now | 379.45% | Needham | Ryan MacDonald | → $14 | Reiterates | → Buy | Get Alert |
04/21/2023 | Buy Now | 276.71% | Cantor Fitzgerald | Sarah James | → $11 | Initiates | → Overweight | Get Alert |
03/14/2023 | Buy Now | 379.45% | Needham | Ryan MacDonald | → $14 | Reiterates | → Buy | Get Alert |
04/19/2022 | Buy Now | 276.71% | Deutsche Bank | Pito Chickering | → $11 | Initiates | → Buy | Get Alert |
01/19/2022 | Buy Now | 379.45% | Stifel | David Grossman | → $14 | Initiates | → Buy | Get Alert |
12/21/2021 | Buy Now | 345.21% | Canaccord Genuity | Richard Close | → $13 | Initiates | → Buy | Get Alert |
12/07/2021 | Buy Now | 379.45% | Needham | Ryan MacDonald | — | Initiates | → Buy | Get Alert |
11/30/2021 | Buy Now | 653.42% | Northland Capital Markets | Michael Latimore | — | Maintains | Outperform | Get Alert |
11/30/2021 | Buy Now | 379.45% | Barclays | Sarah James | — | Initiates | → Overweight | Get Alert |
The latest price target for DocGo (NASDAQ:DCGO) was reported by BTIG on May 9, 2024. The analyst firm set a price target for $7.00 expecting DCGO to rise to within 12 months (a possible 139.73% upside). 24 analyst firms have reported ratings in the last year.
The latest analyst rating for DocGo (NASDAQ:DCGO) was provided by BTIG, and DocGo maintained their buy rating.
There is no last upgrade for DocGo
There is no last downgrade for DocGo.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DocGo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DocGo was filed on May 9, 2024 so you should expect the next rating to be made available sometime around May 9, 2025.
While ratings are subjective and will change, the latest DocGo (DCGO) rating was a maintained with a price target of $11.00 to $7.00. The current price DocGo (DCGO) is trading at is $2.92, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.